Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.20.2
Equity (Tables)
9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
Options Outstanding     Options Exercisable  
Range of Exercise Price     Number Outstanding at September 30, 2020     Weighted Average Remaining Contractual Life (Years)     Weighted Average Exercise Price     Number Exercisable at September 30,
2020
    Weighted Average Exercise
Price
 
$ 0.50       2,000,000       6.36     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,250,000       6.01       1.47       1,748,334       1.43  
  2.00 – 2.80       2,740,000       3.02       2.17       2,740,000       2.17  
  4.76       30,000       3.51       4.76       30,000       4.76  
$ 0.50 – 4.76       7,020,000       4.93     $ 1.48       6,518,334     $ 1.47  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price  
Outstanding at January 1, 2020     5,260,000     $ 1.45  
Granted     1,760,000       1.57  
Terminated / Exercised     -       -  
Outstanding at September 30, 2020     7,020,000     $ 1.48  
Options exercisable at September 30, 2020     6,518,334     $ 1.47  
Options expected to vest     501,666     $ 1.59  
Schedule of nonvested stock options granted
    Number of Options     Weighted Average Exercise Price  
Nonvested at January 1, 2020     264,723     $ 2.00  
Granted     1,760,000       1.57  
Vested     (1,523,057 )     (1.63 )
Nonvested at September 30, 2020     501,666     $ 1.59